ABT-080

N/A

Report date: 2023/02/12 00:15:46
NME

Base Information

Drug NameABT-080
Drug Alias NameABT-080VML-530
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukotriene synthesis inhibitors5-lipoxygenase activating protein inhibitors
Targets5-lipoxygenase activating protein
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott LaboratoriesVernalis Plc
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A